Alexandra Wilson Pecci

1 week ago | pharmavoice.com | Alexandra Wilson Pecci

This audio is auto-generated. Please let us know if you have feedback. When Eli Lilly hired computational pathology expert Thomas Fuchs as the company’s first-ever chief AI officer in October, the announcement showcased pharma’s demand for a very specialized combination of skills. While many AI functions in pharma are outsourced, pharma and biotech companies are building up their internal AI workforces, triggering a higher need for leaders with a background straddling tech and health care.

2 weeks ago | nshoremag.com | Alexandra Wilson Pecci

There’s something special about how the light shines in Marblehead. “The light here is very bright,” says Diana James. “It’s basically sky and water.”James channels this seaside aesthetic every day as founder, principal, and lead designer at Living Swell, a boutique and design studio in the heart of Marblehead’s Old Town. “It exemplifies coastal elegance,” James says of her curated destination. Living Swell has two components.

2 weeks ago | pharmavoice.com | Alexandra Wilson Pecci

This audio is auto-generated. Please let us know if you have feedback. When HHS Secretary Robert F. Kennedy Jr. revealed a plan to require placebo testing for all new vaccine approvals, the agency added few details about the policy shift. The announcement raised alarm bells — and questions — among experts, especially because new vaccines are already tested against placebos. So what would be considered a “new” vaccine under this policy?

3 weeks ago | nshoremag.com | Alexandra Wilson Pecci

For decades, vegetarians and vegans have been searching for good meat substitutes. Although some taste great, their texture often leaves something to be desired. That’s because meat-alternative companies have traditionally made products like burgers, patties, and sausages using extruders, which heat and squeeze plant-based ingredients into something resembling ground meat. The result is held together using binders, thickeners, and gums.

3 weeks ago | pharmavoice.com | Alexandra Wilson Pecci

This audio is auto-generated. Please let us know if you have feedback. Commissioner Dr. Martin Makary’s recent decision to tap outspoken FDA critic, Dr. Vinay Prasad, as head of the Center for Biologics Evaluation and Research has brought the agency’s future into sharper focus.